NCT00025168View on ClinicalTrials.gov

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 1, 2001

Primary Completion Date

August 29, 2003

Study Completion Date

August 29, 2003

Conditions
Pancreatic Cancer
Interventions
DRUG

gemcitabine hydrochloride

DRUG

irinotecan hydrochloride

RADIATION

radiation therapy

Trial Locations (7)

27534

Southeastern Medical Oncology Center, Goldsboro

29303

Spartanburg Regional Healthcare System, Spartanburg

29425

Hollings Cancer Center at Medical University of South Carolina, Charleston

29605

Greenville Hospital System, Greenville

27599-7295

Lineberger Comprehensive Cancer Center, UNC, Chapel Hill

27858-4354

East Carolina University School of Medicine, Greenville

27157-1082

Comprehensive Cancer Center at Wake Forest University, Winston-Salem

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT00025168 - Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer | Biotech Hunter | Biotech Hunter